Literature DB >> 14719055

Imprint cytologic features of pulmonary large cell neuroendocrine carcinoma: Comparison with classic large cell carcinoma.

Akira Iyoda1, Masayuki Baba, Kenzo Hiroshima, Hiroko Saitoh, Yasumitsu Moriya, Kiyoshi Shibuya, Toshihiko Iizasa, Fumio Horiuchi, Hidemi Ohwada, Takehiko Fujisawa.   

Abstract

The World Health Organization (WHO) categorized large cell neuroendocrine carcinoma (LCNEC) as a variant of large cell carcinoma in 1999. However, cytologic features of these tumors have not yet been adequately characterized. The cytologic features of 24 cases of LCNEC were analyzed and compared to the features of 16 cases of classic large cell carcinoma (CLCC). Giant cells, neutrophils and cytophagocytosis were observed more frequently in CLCC than in LCNEC (p<0.05), whereas the unclear border of tumor cells was seen more frequently in LCNEC (p<0.05). The presence of nuclear atypia, such as anisokaryosis, nuclear budding, irregularity of nuclear margins, and multinucleation (having three or more nuclei), was observed less frequently in LCNEC. Characteristic arrangements of tumor cells, such as rosette formation, and palisading, were observed only in LCNEC cases. In morphometric studies, the nuclear areas, cytoplasmic areas, and nuclear rotundity ratios were significantly higher in CLCC cells than in LCNEC cells (p<0.05). However, N/C ratios were significantly higher in LCNEC than in CLCC. LCNEC cells have less nuclear atypia than CLCC cells, and have the characteristic arrangements of tumor cells, such as palisading and rosette. It is possible to preoperatively differentiate LCNEC from CLCC by careful cytologic characterization.

Entities:  

Mesh:

Year:  2004        PMID: 14719055

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

Review 1.  Treatment of lung large cell neuroendocrine carcinoma.

Authors:  Giuseppe Lo Russo; Sara Pusceddu; Claudia Proto; Marianna Macerelli; Diego Signorelli; Milena Vitali; Monica Ganzinelli; Rosaria Gallucci; Nicoletta Zilembo; Marco Platania; Roberto Buzzoni; Filippo de Braud; Marina Chiara Garassino
Journal:  Tumour Biol       Date:  2016-03-04

2.  Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.

Authors:  Juliane Rieber; Julian Schmitt; Arne Warth; Thomas Muley; Jutta Kappes; Florian Eichhorn; Hans Hoffmann; Claus Peter Heussel; Thomas Welzel; Jürgen Debus; Michael Thomas; Martin Steins; Stefan Rieken
Journal:  Eur J Med Res       Date:  2015-08-14       Impact factor: 2.175

3.  High Grade (Large Cell) Neuroendocrine Carcinoma of the Nasopharynx: Novel Case Report with Touch Preparation Cytology and Positive EBV Encoded Early RNA.

Authors:  Charles D Sturgis; Brian B Burkey; Suhael Momin; Aaron P Hoschar
Journal:  Case Rep Pathol       Date:  2015-05-10

4.  Roentgenological occult large-cell neuroendocrine carcinoma: Report of a long-term survivor.

Authors:  Mitsuhiro Kamiyoshihara; Takashi Ibe; Hitoshi Igai; Natsuko Kawatani; Atsushi Takise; Hideaki Itoh; Kimihiro Shimizu
Journal:  Respir Med Case Rep       Date:  2013-01-10

Review 5.  Treatment options for patients with large cell neuroendocrine carcinoma of the lung.

Authors:  Akira Iyoda; Takashi Makino; Satoshi Koezuka; Hajime Otsuka; Yoshinobu Hata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-04-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.